Ditchcarbon
  • Contact
  1. Organizations
  2. Insulet
Public Profile
Medical Device Manufacturing
US
updated a month ago

Insulet Sustainability Profile

Company website

Insulet Corporation, commonly known for its innovative Omnipod® Insulin Management System, is a leading player in the diabetes care industry. Headquartered in the United States, Insulet operates primarily in North America and Europe, focusing on developing advanced insulin delivery solutions. Founded in 2000, the company has achieved significant milestones, including the launch of its tubeless insulin pump, which revolutionised diabetes management for many patients. Insulet's core product, the Omnipod, stands out due to its unique design that offers a wireless, waterproof, and discreet insulin delivery system. This innovative approach has positioned Insulet as a market leader, recognised for enhancing the quality of life for individuals with diabetes. With a commitment to continuous improvement and patient-centric solutions, Insulet remains at the forefront of diabetes technology, driving advancements that empower users to manage their condition effectively.

DitchCarbon Score

How does Insulet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Insulet's score of 33 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Let us know if this data was useful to you

Insulet's reported carbon emissions

In 2024, Insulet Corporation reported total greenhouse gas emissions of approximately 13,830,000 kg CO2e, comprising 1,383,000 kg CO2e from Scope 1 emissions and about 11,467,000 kg CO2e from Scope 2 emissions (market-based). This marks a notable increase in emissions compared to 2023, where total emissions were approximately 5,370,000 kg CO2e, with Scope 1 emissions at 1,316,000 kg CO2e and Scope 2 emissions at about 3,977,000 kg CO2e (market-based). Insulet has made significant strides in reducing its carbon footprint, achieving a 19% reduction in Scope 1 emissions from 2020 to 2021. The company is committed to a net-zero transition, with plans to establish targets for greenhouse gas emissions reduction and increase the use of renewable energy in its operations by 2030. This commitment includes investments in renewable energy and the pursuit of Green Building Index (GBI) and Leadership in Energy and Environmental Design (LEED) certifications for its new manufacturing facility in Malaysia, aimed at minimising environmental impact. Insulet's emissions data is not cascaded from any parent organisation, and all reported figures are derived directly from Insulet Corporation's disclosures. The company continues to develop its blueprint for achieving net-zero emissions by 2050, focusing on both Scope 1 and Scope 2 emissions.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
1,709,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
3,761,000
0,000,000
0,000,000
0,000,000
00,000,000
Scope 3
-
-
-
-
-

How Carbon Intensive is Insulet's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Insulet's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Insulet's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Insulet is in US, which has a low grid carbon intensity relative to other regions.

Insulet's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Insulet has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Insulet's Emissions with Industry Peers

Glooko, Inc.

US
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 15 days ago

Ypsomed

CH
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 9 days ago

embecta

US
•
Food waste for treatment: incineration
Updated 2 months ago

Dexcom

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Terumo

JP
•
Health and social work services (85)
Updated 4 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy